SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GUERRINI, Remo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.475
AS - Asia 12.317
EU - Europa 8.526
SA - Sud America 2.022
AF - Africa 182
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 14
Totale 53.556
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.998
SG - Singapore 5.088
CN - Cina 3.652
DE - Germania 1.817
UA - Ucraina 1.687
BR - Brasile 1.682
IT - Italia 1.425
HK - Hong Kong 1.284
GB - Regno Unito 1.004
TR - Turchia 918
FI - Finlandia 667
VN - Vietnam 617
SE - Svezia 455
RU - Federazione Russa 399
PL - Polonia 345
CA - Canada 242
FR - Francia 206
MX - Messico 191
ID - Indonesia 134
IN - India 134
AR - Argentina 123
JP - Giappone 113
BE - Belgio 103
NL - Olanda 93
ZA - Sudafrica 91
BD - Bangladesh 90
ES - Italia 65
EC - Ecuador 54
AT - Austria 53
LT - Lituania 53
CO - Colombia 41
IQ - Iraq 41
PY - Paraguay 31
CZ - Repubblica Ceca 29
IR - Iran 28
PK - Pakistan 27
IE - Irlanda 26
KR - Corea 26
MA - Marocco 24
CL - Cile 23
VE - Venezuela 22
AE - Emirati Arabi Uniti 20
PE - Perù 20
UZ - Uzbekistan 20
NO - Norvegia 19
SA - Arabia Saudita 18
IL - Israele 17
RO - Romania 16
UY - Uruguay 16
KE - Kenya 14
TN - Tunisia 13
CH - Svizzera 11
AU - Australia 10
AZ - Azerbaigian 10
NP - Nepal 10
DZ - Algeria 9
JO - Giordania 9
LB - Libano 9
EG - Egitto 8
EU - Europa 8
NZ - Nuova Zelanda 8
PH - Filippine 8
TW - Taiwan 8
AL - Albania 7
HN - Honduras 7
SN - Senegal 7
BG - Bulgaria 6
DO - Repubblica Dominicana 6
KZ - Kazakistan 6
MD - Moldavia 6
PA - Panama 6
BO - Bolivia 5
GR - Grecia 5
LV - Lettonia 5
MY - Malesia 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BH - Bahrain 4
ET - Etiopia 4
GE - Georgia 4
JM - Giamaica 4
NI - Nicaragua 4
CI - Costa d'Avorio 3
DK - Danimarca 3
GT - Guatemala 3
GY - Guiana 3
HR - Croazia 3
KH - Cambogia 3
KW - Kuwait 3
LU - Lussemburgo 3
SV - El Salvador 3
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
BY - Bielorussia 2
NG - Nigeria 2
OM - Oman 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 53.530
Salva come PNG Salva come JPEG
Città #
Fairfield 3.528
Woodbridge 3.260
Ashburn 2.860
Singapore 2.816
Houston 2.125
Jacksonville 1.842
Ann Arbor 1.682
Chandler 1.529
Seattle 1.418
Hong Kong 1.277
Wilmington 1.259
Beijing 1.230
Santa Clara 1.200
Cambridge 1.191
Munich 546
Izmir 544
Nanjing 493
Dallas 461
Ferrara 446
Los Angeles 422
Princeton 405
New York 357
San Diego 305
Boardman 303
Warsaw 301
Milan 256
Ho Chi Minh City 227
Falkenstein 195
Helsinki 194
São Paulo 184
Shanghai 180
Shenyang 154
Hefei 152
Nanchang 152
Dearborn 146
Hanoi 132
Falls Church 125
Mexico City 123
Turku 123
London 121
San Mateo 113
Tianjin 107
Jakarta 96
Jiaxing 96
Brussels 95
Tokyo 94
Moscow 88
Brooklyn 86
Addison 84
Hebei 84
Changsha 82
Mountain View 81
Redwood City 77
Buffalo 76
Bremen 74
Norwalk 73
Chicago 71
The Dalles 68
Frankfurt am Main 67
San Francisco 66
Bologna 64
Montreal 62
Jinan 61
Atlanta 60
Toronto 60
Washington 60
Rio de Janeiro 59
Johannesburg 56
Stockholm 54
Philadelphia 53
Zhengzhou 53
Auburn Hills 51
Denver 49
Kunming 45
Orem 45
Belo Horizonte 44
Columbus 43
Guangzhou 42
Phoenix 41
Boston 39
Poplar 39
Montréal 35
Ningbo 35
Tappahannock 34
Brasília 33
Chennai 33
Manchester 31
Curitiba 30
Des Moines 29
Ankara 28
Mcallen 27
Nuremberg 27
Parma 27
St Louis 27
Vienna 27
Dublin 25
Indiana 25
Verona 24
Biên Hòa 23
Charlotte 23
Totale 37.565
Salva come PNG Salva come JPEG
Nome #
Anti-inflammatory and analgesic effects displayed by peptides derived from PKI55 protein, an endogenous protein kinase C inhibitor 348
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 341
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 285
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 254
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 254
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 246
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 238
Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten 237
AGHLDDLPGALSAL: A hemoglobin fragment potentially competing with albumin to bind transition metal ions 234
A new selective antagonist of the nociceptin receptor 233
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 233
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 217
A new ligand for the urotensin II receptor 216
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 214
Designing artificial metalloenzymes exploiting the Spy technology: study of a Cu(II)-Spy construct and perspectives 209
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 209
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 208
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 205
Acid catalysis in the formation of dioxopiperazines from peptides containing tetrahydroisoquinoline‐3‐carboxylic acid at position 2 205
Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor 205
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 204
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 203
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 203
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 201
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 201
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 200
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 199
[Nphe(1)]N/OFQ-(1-13)-NH2 is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K+ channel activation in rat periaqueductal gray slices 197
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 197
Zn(II) and Ni(II) complexes with poly-histidyl peptides derived from a snake venom 196
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 195
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 193
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 193
Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity 192
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 190
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 189
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 188
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 188
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 188
Physicochemical stability of cabazitaxel and docetaxel solutions 186
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 185
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 185
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 185
Pharmacological characterization of tachykinin tetrabranched derivatives 185
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 184
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 183
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 183
[Nphe(1),Arg(14),Lys(15)]N/OFQ-NH2 is a competitive antagonist of NOP receptors in the periaqueductal gray 182
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 181
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides 181
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 181
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 181
Calmodulin Binding Sites of the Skeletal, Cardiac, and Brain Ryanodine Receptor Ca2+ Channels: Modulation by the Catalytic Subunit of cAMP-Dependent Protein Kinase? 179
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 179
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 179
Copper-ion interaction with the 106-113 domain of the prion protein: a solution-equilibria study on model peptides 178
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 176
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 176
Pharmacological characterization of nociceptin receptor: an in vitro study 176
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 175
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 175
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 173
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 172
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 172
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 172
Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex 171
Crystal structures of dipeptides containing the Dmt-Tic pharmacophore 171
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 171
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 170
Pharmacological characterization of the bifunctional opioid ligand H-Dmt-Tic-Gly-NH-Bzl (UFP-505). 169
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 169
Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease 169
Neuropeptide S receptor ligands: a patent review (2005-2016) 168
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 168
Disordered Peptides Looking for Their Native Environment: Structural Basis of CB1 Endocannabinoid Receptor Binding to Pepcans 167
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 167
Design of d-opioid peptide antagonists for emerging drug applications 167
A Single Specific Amino Acid Residue in Peptide Antigens Is Sufficient to Activate Memory CTL: Potential Role of Cross-Reactive Peptides in Memory T Cell Maintenance 166
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 166
[Nphe(1)]-Nociceptin (1-13)-NH2, a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats 165
Effects of [Nphe(1), Arg(14), Lys(15)] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 165
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 165
Structure-activity study at positions 3 and 4 of human neuropeptide S. 164
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 164
Nociceptin/orphanin FQ induces simultaneously anxiolytic and amnesic effects in the mouse elevated T-maze task. 163
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 163
Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH 162
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 162
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 162
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 162
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 161
Cardiovascular effects of nociceptin in unanesthetized mice 160
The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor 160
High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes 159
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 159
Mixed tridentate π-donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals 159
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 158
Nociceptin/Orphanin FQ Receptor Agonists Attenuate L-DOPA-Induced Dyskinesias 158
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5 157
Selective breeding for high anxiety introduces a synonymous SNP that increases neuropeptide s receptor activity 157
Totale 18.916
Salva come PNG Salva come JPEG
Categoria #
all - tutte 258.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.112
Totale 261.565
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.175 0 0 0 0 0 558 184 616 162 700 649 306
2021/20224.133 164 406 403 268 268 173 239 266 143 316 321 1.166
2022/20233.859 417 165 123 473 635 534 194 379 543 21 225 150
2023/20241.915 224 248 114 49 110 296 73 176 41 39 62 483
2024/20258.352 213 185 726 258 995 735 244 608 1.350 842 1.163 1.033
2025/202612.090 2.381 982 2.120 3.012 3.186 409 0 0 0 0 0 0
Totale 54.137